Search for stock quotes, financial statistics and more
Following the company’s fourth quarter results, Raymond James analyst Rahul Sarugaser has chop... Read More
Forecasting a more gradual ramp up for its lead product, Stifel analyst Justin Keywood has trimmed h... Read More
The trend lines look great for HLS Therapeutics (HLS Therapeutics Stock Quote, Charts, News, Analyst... Read More
Clarus Securities analyst Noel Atkinson is sticking with a “Buy” rating on specialty pharma name... Read More
It’s been a rough ride these past two years for fans of specialty pharma company HLS Therapeutics ... Read More
Share
Tweet
pin
Share